Overview of Dr. Mailankody
Dr. Sham Mailankody is an oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from Kansas City University of Medicine and Biosciences College of Osteopathic Medicine and has been in practice 17 years. He is one of 497 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. He has more than 100 publications and over 500 citings.
Office
530 East 74th Street
New York, NY 10021
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2012 - 2015
MedStar Health/Georgetown-Washington Hospital CenterResidency, Internal Medicine, 2009 - 2012
K S Hegde Medical AcademyMBBS, 2001 - 2007
Kansas City University of Medicine and Biosciences College of Osteopathic MedicineClass of 2007
Certifications & Licensure
FL State Medical License 2022 - Present
NY State Medical License 2015 - 2026
NJ State Medical License 2022 - 2025
DC State Medical License 2009 - 2012
Clinical Trials
- Ixazomib (MLN9708) and Dexamethasone in High Risk Smoldering Multiple Myeloma: A Clinical and Correlative Pilot Study Start of enrollment: 2016 Feb 01
- BCMA Targeted CAR T Cells With or Without Lenalidomide for the Treatment of Multiple Myeloma Start of enrollment: 2017 Feb 27
- Short Course Daratumumab in Patients With Multiple Myeloma Start of enrollment: 2018 May 03
Publications & Presentations
PubMed
- Phase I Trial of MCARH109, a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma: An Up...Eric M Jurgens, Ross S Firestone, Jagrutiben Chaudhari, Kinga Hosszu, Sean M Devlin
Journal of Clinical Oncology. 2024-12-04 - Quality of Treatment Selection for Medicare Beneficiaries With Cancer.Aaron P Mitchell, Sonia Persaud, Akriti Mishra Meza, Hannah E Fuchs, Prabal De
Journal of Clinical Oncology. 2024-10-11 - Evaluating serum free light chain ratio as a biomarker in multiple myeloma.Theresia Akhlaghi, Kylee Maclachlan, Neha Korde, Sham Mailankody, Alexander Lesokhin
Haematologica. 2024-10-03
Journal Articles
- Addendum: Low-Value Approvals and High Prices Might Incentivize Ineffective Drug DevelopmentSham Mailankody, MD, Nature
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
